Contraceptive patch: new labeling.
Hellwig
Jennifer P
JP
D000279:Administration, Cutaneous; D000293:Adolescent; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000517:prevention & control; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D005260:Female; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D024821:Metabolic Syndrome / Q000175:diagnosis; D009570:Nitriles; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011724:Pyridazines / Q000627:therapeutic use; D011743:Pyrimidines; D014481:United States; D014810:Vitamin E / Q000627:therapeutic use; D016387:Women's Health
D019380:Anti-HIV Agents; D003271:Contraceptive Agents, Female; D003280:Contraceptives, Oral, Synthetic; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine; D014810:Vitamin E; D001241:Aspirin